Schrader AJ - Search Results

1

Bismarck E, Hammerer P, Merseburger AS, Schrader AJ. Bismarck E, et al. Among authors: schrader aj. Oncol Res Treat. 2020;43 Suppl 2:6-12. doi: 10.1159/000507054. Epub 2020 May 20. Oncol Res Treat. 2020. PMID: 32434198 Free article. Review. German. No abstract available.

2

Frequency and gene expression profile of regulatory T cells in renal cell carcinoma.

Jeron A, Pfoertner S, Bruder D, Geffers R, Hammerer P, Hofmann R, Buer J, Schrader AJ. Jeron A, et al. Among authors: schrader aj. Tumour Biol. 2009;30(3):160-70. doi: 10.1159/000228909. Epub 2009 Jul 16. Tumour Biol. 2009. PMID: 19609102

3

Overexpression of nuclear AR-V7 protein in primary prostate cancer is an independent negative prognostic marker in men with high-risk disease receiving adjuvant therapy.

Chen X, Bernemann C, Tolkach Y, Heller M, Nientiedt C, Falkenstein M, Herpel E, Jenzer M, Grüllich C, Jäger D, Sültmann H, Duensing A, Perner S, Cronauer MV, Stephan C, Debus J, Schrader AJ, Kristiansen G, Hohenfellner M, Duensing S. Chen X, et al. Among authors: schrader aj. Urol Oncol. 2018 Apr;36(4):161.e19-161.e30. doi: 10.1016/j.urolonc.2017.11.001. Epub 2017 Dec 1. Urol Oncol. 2018. PMID: 29198908

4

Expression and functional influence of cellular retinoic acid-binding protein II in renal cell carcinoma.

Goelden U, Pfoertner S, Hansen W, Toepfer T, von Knobloch R, Hofmann R, Buer J, Schrader AJ. Goelden U, et al. Among authors: schrader aj. Urol Int. 2005;75(3):269-76. doi: 10.1159/000087807. Urol Int. 2005. PMID: 16215318

5

Localization of FOXP3-positive cells in renal cell carcinoma.

Sell K, Barth PJ, Moll R, Thomas MA, Zimmer N, Oplesch E, Gudo M, Schrader M, Hofmann R, Schrader AJ. Sell K, et al. Among authors: schrader aj, schrader m. Tumour Biol. 2012 Apr;33(2):507-13. doi: 10.1007/s13277-011-0283-1. Epub 2011 Dec 6. Tumour Biol. 2012. PMID: 22143939

6

Metastatic renal cell carcinoma: recent advances and current therapeutic options.

Schrader AJ, Hofmann R. Schrader AJ, et al. Anticancer Drugs. 2008 Mar;19(3):235-45. doi: 10.1097/cad.0b013e3282f444de. Anticancer Drugs. 2008. PMID: 18510169 Review.

7

Application of real-time reverse transcriptase-polymerase chain reaction in urological oncology.

Schrader AJ, Lauber J, Lechner O, Heidenreich A, Hofmann R, Buer J. Schrader AJ, et al. J Urol. 2003 May;169(5):1858-64. doi: 10.1097/01.ju.0000047363.03411.6b. J Urol. 2003. PMID: 12686862 Review.

8

Urinary collecting system invasion in renal cell carcinoma: incidence and long-term prognosis.

Schrader AJ, Rustemeier J, Varga Z, Hegele A, Olbert PJ, Frohme C, Hofmann R. Schrader AJ, et al. Int J Urol. 2009 Sep;16(9):718-22. doi: 10.1111/j.1442-2042.2009.02353.x. Epub 2009 Jul 29. Int J Urol. 2009. PMID: 19659680

9

Detection of circulating tumor cells in patients with renal cell carcinoma by reverse transcriptase polymerase chain reaction for G250/MNCA-9: results of a prospective trial.

Ohlmann CH, Ozgür E, Schrader AJ, Konrad L, Hofmann R, Engelmann U, Heidenreich A. Ohlmann CH, et al. Among authors: schrader aj. Urol Oncol. 2006 Jul-Aug;24(4):287-93. doi: 10.1016/j.urolonc.2005.10.004. Urol Oncol. 2006. PMID: 16818180

10

In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall.

Olbert PJ, Schrader AJ, Simon C, Dalpke A, Barth P, Hofmann R, Hegele A. Olbert PJ, et al. Among authors: schrader aj. Anticancer Res. 2009 Jun;29(6):2067-76. Anticancer Res. 2009. PMID: 19528466 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

197 results

Search Page